Bridgefront Capital, LLC Bluebird Bio, Inc. Transaction History

Bridgefront Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$3.14 - $8.22 $83,957 - $219,786	26,738 New	26,738 $85,000
Q3 2021 Nov 12, 2021	SELL	$11.24 - $21.0 $138,802 - $259,329	-12,349 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$18.04 - $22.09 $151,066 - $184,981	-8,374 Reduced 40.41%	12,349 $395,000
Q1 2021 May 17, 2021	BUY	$16.59 - $33.89 $343,794 - $702,302	20,723 New	20,723 $625,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $29.3M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.